Cell (25 companies)

Ticker	Company	Therapeutic areas	Programs	Lead stage	Programs
ALLO	Allogene Therapeutics	ImmunologyOncology Rare	12	Phase 2	12
ARTV	Artiva Biotherapeutics	DermatologyImmunology+2 Rare	16	Phase 2	16
AUTL	Autolus Therapeutics	HematologyImmunology+3 Rare	12	Approved	12
BEAM	Beam Therapeutics	HematologyMetabolic+1 Rare	1	Phase 1	7
BCTX	BriaCell Therapeutics	Oncology	6	Phase 3	8
CABA	Cabaletta Bio	DermatologyImmunology+2 Rare	8	Phase 1	8
CAPR	Capricor Therapeutics	Neurology Rare	1	NDA Submitted	1
CRBU	Caribou Biosciences	Oncology	3	Phase 3	4
RNAC	Cartesian Therapeutics	ImmunologyNeurology+1 Rare	4	Phase 3	4
IPSC	Century Therapeutics	ImmunologyMetabolic+1 Rare	10	Phase 1	11
FBIO	Fortress Biotech	DermatologyHematology+1 Rare	1	Approved	12
IMTX	Immatics	Oncology	2	Phase 2	8
IMMX	Immix Biopharma	Hematology Rare	1	Phase 2	1
IBRX	ImmunityBio	Infectious DiseaseOncology	6	NDA Submitted	16
INAB	IN8bio	ImmunologyOncology	5	Phase 2	6
KYTX	Kyverna Therapeutics	ImmunologyNeurology+1 Rare	7	NDA Submitted	7
LGVN	Longeveron	CardiovascularMetabolic+1 Rare	4	Phase 2	4
MRKR	Marker Therapeutics	Oncology	4	Phase 1	4
INKT	MiNK Therapeutics	ImmunologyOncology+1 Rare	7	Phase 2	7
NKTX	Nkarta	ImmunologyNeurology+1 Rare	7	Phase 1	7
OCGN	Ocugen	Infectious DiseaseOphthalmology Rare	1	Phase 3	13
TARA	Protara Therapeutics	DermatologyMetabolic+1 Rare	2	Phase 3	3
SANA	Sana Biotechnology	MetabolicOncology	2	Phase 1	5
TGTX	Tg Therapeutics	Neurology Rare	1	Approved	4
VOR	Vor Biopharma	ImmunologyNeurology Rare	2	Phase 3	4